NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Antibody Infusion Treatment Offers Peace of Mind for People at High Risk for Severe Illness From COVID-19

Monoclonal antibody infusion is shown to significantly reduce the risk of hospitalization or death in people age 65 or older, and those with certain chronic medical conditions, such as diabetes, heart disease, or obesity. Children ages 12 and over who have serious medical conditions may also benefit from the treatment.

“Nationally, individuals with certain risk factors who develop COVID-19 have a 15 percent chance of being hospitalized,” said Brian J. Young, MD, of Penn Medicine Lancaster General Health Physicians Family Medicine Twin Rose. “The infusion treatment reduces that risk to less than 5 percent.”